Lysophospholipid receptor activation of RhoA and lipid signaling pathways

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1831, Issue 1, 2013, Pages 213-222

  Xiang, Sunny Yang ^a   Dusaban, Stephanie S ^a,b   Brown, Joan Heller ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

LPA; Lysophospholipid; RhoA; S1P

Indexed keywords

2 AMINO 2 (3 OCTYLPHENYLCARBAMOYL)ETHYL PHOSPHATE; FINGOLIMOD; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPID; LYSOPHOSPHOLIPID RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOLIPASE C; PHOSPHOLIPASE D; PROTEIN KINASE B; PROTEIN KINASE D; PROTEIN KINASE N; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SPHINGOSINE 1 PHOSPHATE;

AFFINITY CHROMATOGRAPHY; AUTOPHOSPHORYLATION; CELL ADHESION; CELL CYCLE PROGRESSION; CELL MIGRATION; CELL MOTION; CELL PROLIFERATION; CELL SHAPE; CELL SURVIVAL; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE DELETION; GENE EXPRESSION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN DEGRADATION; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; HUMANS; LIPID METABOLISM; LYSOPHOSPHOLIPIDS; MYOCARDIUM; RECEPTORS, LYSOPHOSPHOLIPID; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 84868576048     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2012.09.004     Document Type: Review

References (182)

1. J.D. Saba Lysophospholipids in development: miles apart and edging in J. Cell. Biochem. 92 2004 967 992
2. M. Murph, and G.B. Mills Targeting the lipids LPA and S1P and their signalling pathways to inhibit tumour progression Expert Rev. Mol. Med. 9 2007 1 18
3. D.R. Herr, and J. Chun Effects of LPA and S1P on the nervous system and implications for their involvement in disease Curr. Drug Targets 8 2007 155 167
4. C.W. Lee, J.W. Choi, and J. Chun Neurological S1P signaling as an emerging mechanism of action of oral FTY720 (fingolimod) in multiple sclerosis Arch. Pharm. Res. 33 2010 1567 1574
5. K. Noguchi, and J. Chun Roles for lysophospholipid S1P receptors in multiple sclerosis Crit. Rev. Biochem. Mol. Biol. 46 2011 2 10
6. M.E. Lin, D.R. Herr, and J. Chun Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance Prostaglandins Other Lipid Mediat. 91 2010 130 138
7. M. Maceyka, K.B. Harikumar, S. Milstien, and S. Spiegel Sphingosine-1-phosphate signaling and its role in disease Trends Cell Biol. 22 2012 50 60
8. J.S. Karliner, and J.H. Brown Lipid signalling in cardiovascular pathophysiology Cardiovasc. Res. 82 2009 171 174
9. C.K. Means, and J.H. Brown Sphingosine-1-phosphate receptor signalling in the heart Cardiovasc. Res. 82 2009 193 200
10. T. Mutoh, R. Rivera, and J. Chun Insights into the pharmacological relevance of lysophospholipid receptors Br. J. Pharmacol. 165 2012 829 844
11. J.W. Choi, D.R. Herr, K. Noguchi, Y.C. Yung, C.W. Lee, T. Mutoh, M.E. Lin, S.T. Teo, K.E. Park, A.N. Mosley, and J. Chun LPA receptors: subtypes and biological actions Annu. Rev. Pharmacol. Toxicol. 50 2010 157 186
12. N.A. Riobo, and D.R. Manning Receptors coupled to heterotrimeric G proteins of the G12 family Trends Pharmacol. Sci. 26 2005 146 154
13. D. Meyer zu Heringdorf, and K.H. Jakobs Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism Biochim. Biophys. Acta 1768 2007 923 940
14. P.C. Sternweis, A.M. Carter, Z. Chen, S.M. Danesh, Y.F. Hsiung, and W.D. Singer Regulation of Rho guanine nucleotide exchange factors by G proteins Adv. Protein Chem. 74 2007 189 228
15. M. Aittaleb, C.A. Boguth, and J.J. Tesmer Structure and function of heterotrimeric G protein-regulated Rho guanine nucleotide exchange factors Mol. Pharmacol. 77 2010 111 125
16. N. Suzuki, N. Hajicek, and T. Kozasa Regulation and physiological functions of G12/13-mediated signaling pathways Neurosignals 17 2009 55 70
17. S. Siehler Regulation of RhoGEF proteins by G12/13-coupled receptors Br. J. Pharmacol. 158 2009 41 49
18. S. Narumiya, M. Tanji, and T. Ishizaki Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion Cancer Metastasis Rev. 28 2009 65 76
19. S. Miyamoto, D.P. Del Re, S.Y. Xiang, X. Zhao, G. Florholmen, and J.H. Brown Revisited and revised: is RhoA always a villain in cardiac pathophysiology? J. Cardiovasc. Transl. Res. 3 2010 330 343
20. A.B. Jaffe, and A. Hall Rho GTPases: biochemistry and biology Annu. Rev. Cell Dev. Biol. 21 2005 247 269
21. M. Amano, K. Chihara, K. Kimura, Y. Fukata, N. Nakamura, Y. Matsuura, and K. Kaibuchi Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase Science 275 1997 1308 1311
22. M. Chrzanowska-Wodnicka, and K. Burridge Rho-stimulated contractility drives the formation of stress fibers and focal adhesions J. Cell Biol. 133 1996 1403 1415
23. L.K. Needham, and E. Rozengurt Galpha12 and Galpha13 stimulate Rho-dependent tyrosine phosphorylation of focal adhesion kinase, paxillin, and p130 Crk-associated substrate J. Biol. Chem. 273 1998 14626 14632
24. D. Bian, C. Mahanivong, J. Yu, S.M. Frisch, Z.K. Pan, R.D. Ye, and S. Huang The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration Oncogene 25 2006 2234 2244
25. H. Katoh, J. Aoki, Y. Yamaguchi, Y. Kitano, A. Ichikawa, and M. Negishi Constitutively active Galpha12, Galpha13, and Galphaq induce Rho-dependent neurite retraction through different signaling pathways J. Biol. Chem. 273 1998 28700 28707
26. O. Kranenburg, M. Poland, F.P. van Horck, D. Drechsel, A. Hall, and W.H. Moolenaar Activation of RhoA by lysophosphatidic acid and Galpha12/13 subunits in neuronal cells: induction of neurite retraction Mol. Biol. Cell 10 1999 1851 1857
27. J. Radeff-Huang, T.M. Seasholtz, R.G. Matteo, and J.H. Brown G protein mediated signaling pathways in lysophospholipid induced cell proliferation and survival J. Cell. Biochem. 92 2004 949 966
28. C.S. Hill, J. Wynne, and R. Treisman The Rho family GTPases RhoA, Rac1, and CDC42Hs regulate transcriptional activation by SRF Cell 81 1995 1159 1170
29. M.J. Hart, X. Jiang, T. Kozasa, W. Roscoe, W.D. Singer, A.G. Gilman, P.C. Sternweis, and G. Bollag Direct stimulation of the guanine nucleotide exchange activity of p115 RhoGEF by Galpha13 Science 280 1998 2112 2114
30. T. Kozasa, X. Jiang, M.J. Hart, P.M. Sternweis, W.D. Singer, A.G. Gilman, G. Bollag, and P.C. Sternweis p115 RhoGEF, a GTPase activating protein for Galpha12 and Galpha13 Science 280 1998 2109 2111
31. M. Aittaleb, A. Nishimura, M.E. Linder, and J.J. Tesmer Plasma membrane association of p63 Rho guanine nucleotide exchange factor (p63RhoGEF) is mediated by palmitoylation and is required for basal activity in cells J. Biol. Chem. 286 2011 34448 34456
32. S. Lutz, A. Shankaranarayanan, C. Coco, M. Ridilla, M.R. Nance, C. Vettel, D. Baltus, C.R. Evelyn, R.R. Neubig, T. Wieland, and J.J. Tesmer Structure of Galphaq-p63RhoGEF-RhoA complex reveals a pathway for the activation of RhoA by GPCRs Science 318 2007 1923 1927
33. H. Drissi, F. Lasmoles, V. Le Mellay, P.J. Marie, and M. Lieberherr Activation of phospholipase C-beta1 via Galphaq/11 during calcium mobilization by calcitonin gene-related peptide J. Biol. Chem. 273 1998 20168 20174
34. A.M. Lyon, V.M. Tesmer, V.D. Dhamsania, D.M. Thal, J. Gutierrez, S. Chowdhury, K.C. Suddala, J.K. Northup, and J.J. Tesmer An autoinhibitory helix in the C-terminal region of phospholipase C-beta mediates Galphaq activation Nat. Struct. Mol. Biol. 18 2011 999 1005
35. G.L. Waldo, T.K. Ricks, S.N. Hicks, M.L. Cheever, T. Kawano, K. Tsuboi, X. Wang, C. Montell, T. Kozasa, J. Sondek, and T.K. Harden Kinetic scaffolding mediated by a phospholipase C-beta and Gq signaling complex Science 330 2010 974 980
36. A.V. Smrcka, J.R. Hepler, K.O. Brown, and P.C. Sternweis Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq Science 251 1991 804 807
37. S.J. Taylor, H.Z. Chae, S.G. Rhee, and J.H. Exton Activation of the beta 1 isozyme of phospholipase C by alpha subunits of the Gq class of G proteins Nature 350 1991 516 518
38. J.H. Brown, D.P. Del Re, and M.A. Sussman The Rac and Rho hall of fame: a decade of hypertrophic signaling hits Circ. Res. 98 2006 730 742
39. C.L. Hutchinson, P.N. Lowe, S.H. McLaughlin, H.R. Mott, and D. Owen Mutational analysis reveals a single binding interface between RhoA and its effector, PRK1 Biochemistry 50 2011 2860 2869
40. A.L. Bishop, and A. Hall Rho GTPases and their effector proteins Biochem. J. 348 Pt 2 2000 241 255
41. K. Riento, and A.J. Ridley Rocks: multifunctional kinases in cell behaviour Nat. Rev. Mol. Cell Biol. 4 2003 446 456
42. M. Surma, L. Wei, and J. Shi Rho kinase as a therapeutic target in cardiovascular disease Future Cardiol. 7 2011 657 671
43. C.A. Street, and B.A. Bryan Rho kinase proteins - pleiotropic modulators of cell survival and apoptosis Anticancer Res. 31 2011 3645 3657
44. W.G. Lim, X. Chen, J.P. Liu, B.J. Tan, S. Zhou, A. Smith, N. Lees, L. Hou, F. Gu, X.Y. Yu, Y. Du, D. Smith, C. Verma, K. Liu, and W. Duan The C-terminus of PRK2/PKNgamma is required for optimal activation by RhoA in a GTP-dependent manner Arch. Biochem. Biophys. 479 2008 170 178
45. A. Schmidt, J. Durgan, A. Magalhaes, and A. Hall Rho GTPases regulate PRK2/PKN2 to control entry into mitosis and exit from cytokinesis EMBO J. 26 2007 1624 1636
46. M. Amano, H. Mukai, Y. Ono, K. Chihara, T. Matsui, Y. Hamajima, K. Okawa, A. Iwamatsu, and K. Kaibuchi Identification of a putative target for Rho as the serine-threonine kinase protein kinase N Science 271 1996 648 650
47. G. Watanabe, Y. Saito, P. Madaule, T. Ishizaki, K. Fujisawa, N. Morii, H. Mukai, Y. Ono, A. Kakizuka, and S. Narumiya Protein kinase N (PKN) and PKN-related protein rhophilin as targets of small GTPase Rho Science 271 1996 645 648
48. H. Mukai The structure and function of PKN, a protein kinase having a catalytic domain homologous to that of PKC J. Biochem. 133 2003 17 27
49. H. Takagi, C.P. Hsu, K. Kajimoto, D. Shao, Y. Yang, Y. Maejima, P. Zhai, G. Yehia, C. Yamada, D. Zablocki, and J. Sadoshima Activation of PKN mediates survival of cardiac myocytes in the heart during ischemia/reperfusion Circ. Res. 107 2010 642 649
50. S. Cockcroft Signalling roles of mammalian phospholipase D1 and D2 Cell. Mol. Life Sci. 58 2001 1674 1687
51. J.H. Exton Regulation of phospholipase D FEBS Lett. 531 2002 58 61
52. G.M. Jenkins, and M.A. Frohman Phospholipase D: a lipid centric review Cell. Mol. Life Sci. 62 2005 2305 2316
53. P.A. Oude Weernink, M. Lopez de Jesus, and M. Schmidt Phospholipase D signaling: orchestration by PIP2 and small GTPases Naunyn Schmiedebergs Arch. Pharmacol. 374 2007 399 411
54. Z. Xie, W.T. Ho, R. Spellman, S. Cai, and J.H. Exton Mechanisms of regulation of phospholipase D1 and D2 by the heterotrimeric G proteins G13 and Gq J. Biol. Chem. 277 2002 11979 11986
55. F. Gaits, O. Fourcade, F. Le Balle, G. Gueguen, B. Gaige, A. Gassama-Diagne, J. Fauvel, J.P. Salles, G. Mauco, M.F. Simon, and H. Chap Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis FEBS Lett. 410 1997 54 58
56. M. Yamazaki, Y. Zhang, H. Watanabe, T. Yokozeki, S. Ohno, K. Kaibuchi, H. Shibata, H. Mukai, Y. Ono, M.A. Frohman, and Y. Kanaho Interaction of the small G protein RhoA with the C terminus of human phospholipase D1 J. Biol. Chem. 274 1999 6035 6038
57. S.J. Walker, and H.A. Brown Specificity of Rho insert-mediated activation of phospholipase D1 J. Biol. Chem. 277 2002 26260 26267
58. K. Oishi, M. Takahashi, H. Mukai, Y. Banno, S. Nakashima, Y. Kanaho, Y. Nozawa, and Y. Ono PKN regulates phospholipase D1 through direct interaction J. Biol. Chem. 276 2001 18096 18101
59. L.D. Chong, A. Traynor-Kaplan, G.M. Bokoch, and M.A. Schwartz The small GTP-binding protein Rho regulates a phosphatidylinositol 4-phosphate 5-kinase in mammalian cells Cell 79 1994 507 513
60. L. Wang, R. Cummings, P. Usatyuk, A. Morris, K. Irani, and V. Natarajan Involvement of phospholipases D1 and D2 in sphingosine 1-phosphate-induced ERK (extracellular-signal-regulated kinase) activation and interleukin-8 secretion in human bronchial epithelial cells Biochem. J. 367 2002 751 760
61. R.J. Cummings, N.L. Parinandi, A. Zaiman, L. Wang, P.V. Usatyuk, J.G. Garcia, and V. Natarajan Phospholipase D activation by sphingosine 1-phosphate regulates interleukin-8 secretion in human bronchial epithelial cells J. Biol. Chem. 277 2002 30227 30235
62. E. Meacci, F. Nuti, S. Catarzi, V. Vasta, C. Donati, S. Bourgoin, P. Bruni, J. Moss, and M. Vaughan Activation of phospholipase D by bradykinin and sphingosine 1-phosphate in A549 human lung adenocarcinoma cells via different GTP-binding proteins and protein kinase C delta signaling pathways Biochemistry 42 2003 284 292
63. C. Qi, J.H. Park, T.C. Gibbs, D.W. Shirley, C.D. Bradshaw, K.M. Ella, and K.E. Meier Lysophosphatidic acid stimulates phospholipase D activity and cell proliferation in PC-3 human prostate cancer cells J. Cell. Physiol. 174 1998 261 272
64. R.L. van der Bend, J. de Widt, E.J. van Corven, W.H. Moolenaar, and W.J. van Blitterswijk The biologically active phospholipid, lysophosphatidic acid, induces phosphatidylcholine breakdown in fibroblasts via activation of phospholipase D. Comparison with the response to endothelin Biochem. J. 285 Pt 1 1992 235 240
65. P.S. Tappia, M.R. Dent, and N.S. Dhalla Oxidative stress and redox regulation of phospholipase D in myocardial disease Free Radic. Biol. Med. 41 2006 349 361
66. N.L. Parinandi, W.M. Scribner, S. Vepa, S. Shi, and V. Natarajan Phospholipase D activation in endothelial cells is redox sensitive Antioxid. Redox Signal. 1 1999 193 210
67. A. Aghajanian, E.S. Wittchen, S.L. Campbell, and K. Burridge Direct activation of RhoA by reactive oxygen species requires a redox-sensitive motif PLoS One 4 2009 e8045
68. J. Heo, K.W. Raines, V. Mocanu, and S.L. Campbell Redox regulation of RhoA Biochemistry 45 2006 14481 14489
69. S.Y. Xiang, D. Vanhoutte, D.P. Del Re, N.H. Purcell, H. Ling, I. Banerjee, J. Bossuyt, R.A. Lang, Y. Zheng, S.J. Matkovich, S. Miyamoto, J.D. Molkentin, G.W. Dorn II, and J.H. Brown RhoA protects the mouse heart against ischemia/reperfusion injury J. Clin. Invest. 121 2011 3269 3276
70. S. Mozzicato, B.V. Joshi, K.A. Jacobson, and B.T. Liang Role of direct RhoA-phospholipase D1 interaction in mediating adenosine-induced protection from cardiac ischemia FASEB J. 18 2004 406 408
71. M.V. Cohen, Y. Liu, G.S. Liu, P. Wang, C. Weinbrenner, G.A. Cordis, D.K. Das, and J.M. Downey Phospholipase D plays a role in ischemic preconditioning in rabbit heart Circulation 94 1996 1713 1718
72. A. Tosaki, N. Maulik, G. Cordis, O.C. Trifan, L.M. Popescu, and D.K. Das Ischemic preconditioning triggers phospholipase D signaling in rat heart Am. J. Physiol. 273 1997 H1860 H1866
73. D.A. Vessey, L. Li, N. Honbo, and J.S. Karliner Sphingosine 1-phosphate is an important endogenous cardioprotectant released by ischemic pre- and postconditioning Am. J. Physiol. Heart Circ. Physiol. 297 2009 H1429 H1435
74. D.A. Vessey, L. Li, M. Kelley, J. Zhang, and J.S. Karliner Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate J. Biochem. Mol. Toxicol. 22 2008 113 118
75. M. Santarius, C.H. Lee, and R.A. Anderson Supervised membrane swimming: small G-protein lifeguards regulate PIPK signalling and monitor intracellular PtdIns(4,5)P2 pools Biochem. J. 398 2006 1 13
76. M. Schmidt, C. Bienek, U. Rumenapp, C. Zhang, G. Lummen, K.H. Jakobs, I. Just, K. Aktories, M. Moos, and C. von Eichel-Streiber A role for Rho in receptor- and G protein-stimulated phospholipase C. Reduction in phosphatidylinositol 4,5-bisphosphate by Clostridium difficile toxin B Naunyn Schmiedebergs Arch. Pharmacol. 354 1996 87 94
77. X.D. Ren, G.M. Bokoch, A. Traynor-Kaplan, G.H. Jenkins, R.A. Anderson, and M.A. Schwartz Physical association of the small GTPase Rho with a 68-kDa phosphatidylinositol 4-phosphate 5-kinase in Swiss 3T3 cells Mol. Biol. Cell 7 1996 435 442
78. P.A. Oude Weernink, P. Schulte, Y. Guo, J. Wetzel, M. Amano, K. Kaibuchi, S. Haverland, M. Voss, M. Schmidt, G.W. Mayr, and K.H. Jakobs Stimulation of phosphatidylinositol-4-phosphate 5-kinase by Rho-kinase J. Biol. Chem. 275 2000 10168 10174
79. M.D. Hains, M.R. Wing, S. Maddileti, D.P. Siderovski, and T.K. Harden Galpha12/13- and rho-dependent activation of phospholipase C-epsilon by lysophosphatidic acid and thrombin receptors Mol. Pharmacol. 69 2006 2068 2075
80. G.G. Kelley, S.E. Reks, J.M. Ondrako, and A.V. Smrcka Phospholipase C(epsilon): a novel Ras effector EMBO J. 20 2001 743 754
81. J.P. Seifert, M.R. Wing, J.T. Snyder, S. Gershburg, J. Sondek, and T.K. Harden RhoA activates purified phospholipase C-epsilon by a guanine nucleotide-dependent mechanism J. Biol. Chem. 279 2004 47992 47997
82. M.R. Wing, J.T. Snyder, J. Sondek, and T.K. Harden Direct activation of phospholipase C-epsilon by Rho J. Biol. Chem. 278 2003 41253 41258
83. T.D. Bunney, and M. Katan Phospholipase C epsilon: linking second messengers and small GTPases Trends Cell Biol. 16 2006 640 648
84. A.V. Smrcka, J.H. Brown, and G.G. Holz Role of phospholipase Cepsilon in physiological phosphoinositide signaling networks Cell. Signal. 24 2012 1333 1343
85. M.R. Wing, D.M. Bourdon, and T.K. Harden PLC-epsilon: a shared effector protein in Ras-, Rho-, and G alpha beta gamma-mediated signaling Mol. Interv. 3 2003 273 280
86. T. Satoh, H. Edamatsu, and T. Kataoka Phospholipase Cepsilon guanine nucleotide exchange factor activity and activation of Rap1 Methods Enzymol. 407 2006 281 290
87. H. Edamatsu, T. Satoh, and T. Kataoka Ras and Rap1 activation of PLCepsilon lipase activity Methods Enzymol. 407 2006 99 107
88. M. Schmidt, S. Evellin, P.A. Weernink, F. von Dorp, H. Rehmann, J.W. Lomasney, and K.H. Jakobs A new phospholipase-C-calcium signalling pathway mediated by cyclic AMP and a Rap GTPase Nat. Cell Biol. 3 2001 1020 1024
89. I. Lopez, E.C. Mak, J. Ding, H.E. Hamm, and J.W. Lomasney A novel bifunctional phospholipase c that is regulated by Galpha 12 and stimulates the Ras/mitogen-activated protein kinase pathway J. Biol. Chem. 276 2001 2758 2765
90. G.G. Kelley, S.E. Reks, and A.V. Smrcka Hormonal regulation of phospholipase Cepsilon through distinct and overlapping pathways involving G12 and Ras family G-proteins Biochem. J. 378 2004 129 139
91. S. Citro, S. Malik, E.A. Oestreich, J. Radeff-Huang, G.G. Kelley, A.V. Smrcka, and J.H. Brown Phospholipase Cepsilon is a nexus for Rho and Rap-mediated G protein-coupled receptor-induced astrocyte proliferation Proc. Natl. Acad. Sci. U. S. A. 104 2007 15543 15548
92. H. Wang, E.A. Oestreich, N. Maekawa, T.A. Bullard, K.L. Vikstrom, R.T. Dirksen, G.G. Kelley, B.C. Blaxall, and A.V. Smrcka Phospholipase C epsilon modulates beta-adrenergic receptor-dependent cardiac contraction and inhibits cardiac hypertrophy Circ. Res. 97 2005 1305 1313
93. M. Li, H. Edamatsu, R. Kitazawa, S. Kitazawa, and T. Kataoka Phospholipase Cepsilon promotes intestinal tumorigenesis of Apc(Min/+) mice through augmentation of inflammation and angiogenesis Carcinogenesis 30 2009 1424 1432
94. M. Oka, H. Edamatsu, M. Kunisada, L. Hu, N. Takenaka, M. Sakaguchi, T. Kataoka, and C. Nishigori Phospholipase Cvarepsilon has a crucial role in ultraviolet B-induced neutrophil-associated skin inflammation by regulating the expression of CXCL1/KC Lab. Invest. 91 2011 711 718
95. Y. Fu, and C.S. Rubin Protein kinase D: coupling extracellular stimuli to the regulation of cell physiology EMBO Rep. 12 2011 785 796
96. Q.J. Wang PKD at the crossroads of DAG and PKC signaling Trends Pharmacol. Sci. 27 2006 317 323
97. E. Rozengurt, O. Rey, and R.T. Waldron Protein kinase D signaling J. Biol. Chem. 280 2005 13205 13208
98. J. Yuan, L.W. Slice, and E. Rozengurt Activation of protein kinase D by signaling through Rho and the alpha subunit of the heterotrimeric G protein G13 J. Biol. Chem. 276 2001 38619 38627
99. C.F. Cowell, I.K. Yan, T. Eiseler, A.C. Leightner, H. Doppler, and P. Storz Loss of cell-cell contacts induces NF-kappaB via RhoA-mediated activation of protein kinase D1 J. Cell. Biochem. 106 2009 714 728
100. J. Van Lint, A. Rykx, Y. Maeda, T. Vantus, S. Sturany, V. Malhotra, J.R. Vandenheede, and T. Seufferlein Protein kinase D: an intracellular traffic regulator on the move Trends Cell Biol. 12 2002 193 200
101. M.T. Kunkel, E.L. Garcia, T. Kajimoto, R.A. Hall, and A.C. Newton The protein scaffold NHERF-1 controls the amplitude and duration of localized protein kinase D activity J. Biol. Chem. 284 2009 24653 24661
102. M.T. Kunkel, A. Toker, R.Y. Tsien, and A.C. Newton Calcium-dependent regulation of protein kinase D revealed by a genetically encoded kinase activity reporter J. Biol. Chem. 282 2007 6733 6742
103. T.G. Jin, T. Satoh, Y. Liao, C. Song, X. Gao, K. Kariya, C.D. Hu, and T. Kataoka Role of the CDC25 homology domain of phospholipase Cepsilon in amplification of Rap1-dependent signaling J. Biol. Chem. 276 2001 30301 30307
104. M. Avkiran, A.J. Rowland, F. Cuello, and R.S. Haworth Protein kinase d in the cardiovascular system: emerging roles in health and disease Circ. Res. 102 2008 157 163
105. J. Fielitz, M.S. Kim, J.M. Shelton, X. Qi, J.A. Hill, J.A. Richardson, R. Bassel-Duby, and E.N. Olson Requirement of protein kinase D1 for pathological cardiac remodeling Proc. Natl. Acad. Sci. U. S. A. 105 2008 3059 3063
106. C.H. Ha, W. Wang, B.S. Jhun, C. Wong, A. Hausser, K. Pfizenmaier, T.A. McKinsey, E.N. Olson, and Z.G. Jin Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis J. Biol. Chem. 283 2008 14590 14599
107. R.B. Vega, B.C. Harrison, E. Meadows, C.R. Roberts, P.J. Papst, E.N. Olson, and T.A. McKinsey Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5 Mol. Cell. Biol. 24 2004 8374 8385
108. H. Doppler, and P. Storz A novel tyrosine phosphorylation site in protein kinase D contributes to oxidative stress-mediated activation J. Biol. Chem. 282 2007 31873 31881
109. C.F. Cowell, H. Doppler, I.K. Yan, A. Hausser, Y. Umezawa, and P. Storz Mitochondrial diacylglycerol initiates protein-kinase D1-mediated ROS signaling J. Cell Sci. 122 2009 919 928
110. P. Storz, H. Doppler, and A. Toker Protein kinase D mediates mitochondrion-to-nucleus signaling and detoxification from mitochondrial reactive oxygen species Mol. Cell. Biol. 25 2005 8520 8530
111. P. Storz, H. Doppler, F.J. Johannes, and A. Toker Tyrosine phosphorylation of protein kinase D in the pleckstrin homology domain leads to activation J. Biol. Chem. 278 2003 17969 17976
112. P. Storz, and A. Toker Protein kinase D mediates a stress-induced NF-kappaB activation and survival pathway EMBO J. 22 2003 109 120
113. B.D. Manning, and L.C. Cantley AKT/PKB signaling: navigating downstream Cell 129 2007 1261 1274
114. M.A. Sussman, M. Volkers, K. Fischer, B. Bailey, C.T. Cottage, S. Din, N. Gude, D. Avitabile, R. Alvarez, B. Sundararaman, P. Quijada, M. Mason, M.H. Konstandin, A. Malhowski, Z. Cheng, M. Khan, and M. McGregor Myocardial AKT: the omnipresent nexus Physiol. Rev. 91 2011 1023 1070
115. L.M. Baudhuin, K.L. Cristina, J. Lu, and Y. Xu Akt activation induced by lysophosphatidic acid and sphingosine-1-phosphate requires both mitogen-activated protein kinase kinase and p38 mitogen-activated protein kinase and is cell-line specific Mol. Pharmacol. 62 2002 660 671
116. C.K. Means, C.Y. Xiao, Z. Li, T. Zhang, J.H. Omens, I. Ishii, J. Chun, and J.H. Brown Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury Am. J. Physiol. Heart Circ. Physiol. 292 2007 H2944 H2951
117. C.K. Means, S. Miyamoto, J. Chun, and J.H. Brown S1P1 receptor localization confers selectivity for Gi-mediated cAMP and contractile responses J. Biol. Chem. 283 2008 11954 11963
118. S. Bonnaud, C. Niaudet, F. Legoux, I. Corre, G. Delpon, X. Saulquin, Z. Fuks, M.H. Gaugler, R. Kolesnick, and F. Paris Sphingosine-1-phosphate activates the AKT pathway to protect small intestines from radiation-induced endothelial apoptosis Cancer Res. 70 2010 9905 9915
119. J. Igarashi, S.G. Bernier, and T. Michel Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells J. Biol. Chem. 276 2001 12420 12426
120. D.P. Del Re, S. Miyamoto, and J.H. Brown Focal adhesion kinase as a RhoA-activable signaling scaffold mediating Akt activation and cardiomyocyte protection J. Biol. Chem. 283 2008 35622 35629
121. P. Xie, D.D. Browning, N. Hay, N. Mackman, and R.D. Ye Activation of NF-kappa B by bradykinin through a Galpha(q)- and Gbeta gamma-dependent pathway that involves phosphoinositide 3-kinase and Akt J. Biol. Chem. 275 2000 24907 24914
122. L.M. Gervitz, D. Nalbant, S.C. Williams, and J.C. Fowler Adenosine-mediated activation of Akt/protein kinase B in the rat hippocampus in vitro and in vivo Neurosci. Lett. 328 2002 175 179
123. S. Miyamoto, A.N. Murphy, and J.H. Brown Akt mediated mitochondrial protection in the heart: metabolic and survival pathways to the rescue J. Bioenerg. Biomembr. 41 2009 169 180
124. N. Gude, J. Muraski, M. Rubio, J. Kajstura, E. Schaefer, P. Anversa, and M.A. Sussman Akt promotes increased cardiomyocyte cycling and expansion of the cardiac progenitor cell population Circ. Res. 99 2006 381 388
125. I. Shiojima, and K. Walsh Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway Genes Dev. 20 2006 3347 3365
126. S. Miyamoto, N.H. Purcell, J.M. Smith, T. Gao, R. Whittaker, K. Huang, R. Castillo, C.C. Glembotski, M.A. Sussman, A.C. Newton, and J.H. Brown PHLPP-1 negatively regulates Akt activity and survival in the heart Circ. Res. 107 2010 476 484
127. N. Noshita, A. Lewen, T. Sugawara, and P.H. Chan Akt phosphorylation and neuronal survival after traumatic brain injury in mice Neurobiol. Dis. 9 2002 294 304
128. H. Endo, C. Nito, H. Kamada, F. Yu, and P.H. Chan Akt/GSK3beta survival signaling is involved in acute brain injury after subarachnoid hemorrhage in rats Stroke 37 2006 2140 2146
129. J. Li, C. Yen, D. Liaw, K. Podsypanina, S. Bose, S.I. Wang, J. Puc, C. Miliaresis, L. Rodgers, R. McCombie, S.H. Bigner, B.C. Giovanella, M. Ittmann, B. Tycko, H. Hibshoosh, M.H. Wigler, and R. Parsons PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer Science 275 1997 1943 1947
130. H. Sun, R. Lesche, D.M. Li, J. Liliental, H. Zhang, J. Gao, N. Gavrilova, B. Mueller, X. Liu, and H. Wu PTEN modulates cell cycle progression and cell survival by regulating phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B signaling pathway Proc. Natl. Acad. Sci. U. S. A. 96 1999 6199 6204
131. T. Sanchez, S. Thangada, M.T. Wu, C.D. Kontos, D. Wu, H. Wu, and T. Hla PTEN as an effector in the signaling of antimigratory G protein-coupled receptor Proc. Natl. Acad. Sci. U. S. A. 102 2005 4312 4317
132. Z. Li, X. Dong, Z. Wang, W. Liu, N. Deng, Y. Ding, L. Tang, T. Hla, R. Zeng, L. Li, and D. Wu Regulation of PTEN by Rho small GTPases Nat. Cell Biol. 7 2005 399 404
133. E. Malchinkhuu, K. Sato, T. Maehama, C. Mogi, H. Tomura, S. Ishiuchi, Y. Yoshimoto, H. Kurose, and F. Okajima S1P(2) receptors mediate inhibition of glioma cell migration through Rho signaling pathways independent of PTEN Biochem. Biophys. Res. Commun. 366 2008 963 968
134. P. Keul, K. Sattler, and B. Levkau HDL and its sphingosine-1-phosphate content in cardioprotection Heart Fail. Rev. 12 2007 301 306
135. G. Theilmeier, C. Schmidt, J. Herrmann, P. Keul, M. Schafers, I. Herrgott, J. Mersmann, J. Larmann, S. Hermann, J. Stypmann, O. Schober, R. Hildebrand, R. Schulz, G. Heusch, M. Haude, K. von Wnuck Lipinski, C. Herzog, M. Schmitz, R. Erbel, J. Chun, and B. Levkau High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor Circulation 114 2006 1403 1409
136. Z.Q. Jin, H.Z. Zhou, P. Zhu, N. Honbo, D. Mochly-Rosen, R.O. Messing, E.J. Goetzl, J.S. Karliner, and M.O. Gray Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts Am. J. Physiol. Heart Circ. Physiol. 282 2002 H1970 H1977
137. D.A. Vessey, L. Li, M. Kelley, and J.S. Karliner Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia Biochem. Biophys. Res. Commun. 375 2008 425 429
138. V. Brinkmann, M.D. Davis, C.E. Heise, R. Albert, S. Cottens, R. Hof, C. Bruns, E. Prieschl, T. Baumruker, P. Hiestand, C.A. Foster, M. Zollinger, and K.R. Lynch The immune modulator FTY720 targets sphingosine 1-phosphate receptors J. Biol. Chem. 277 2002 21453 21457
139. V. Brinkmann, and K.R. Lynch FTY720: targeting G-protein-coupled receptors for sphingosine 1-phosphate in transplantation and autoimmunity Curr. Opin. Immunol. 14 2002 569 575
140. U. Hofmann, K. Hu, F. Walter, N. Burkard, G. Ertl, J. Bauersachs, O. Ritter, S. Frantz, and A. Bonz Pharmacological pre- and post-conditioning with the sphingosine-1-phosphate receptor modulator FTY720 after myocardial ischaemia-reperfusion Br. J. Pharmacol. 160 2010 1243 1251
141. U. Hofmann, N. Burkard, C. Vogt, A. Thoma, S. Frantz, G. Ertl, O. Ritter, and A. Bonz Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion Cardiovasc. Res. 83 2009 285 293
142. Y.T. Tsukada, M.G. Sanna, H. Rosen, and R.A. Gottlieb S1P1-selective agonist SEW2871 exacerbates reperfusion arrhythmias J. Cardiovasc. Pharmacol. 50 2007 660 669
143. M.G. Sanna, J. Liao, E. Jo, C. Alfonso, M.Y. Ahn, M.S. Peterson, B. Webb, S. Lefebvre, J. Chun, N. Gray, and H. Rosen Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate J. Biol. Chem. 279 2004 13839 13848
144. L.K. Landeen, D.A. Dederko, C.S. Kondo, B.S. Hu, N. Aroonsakool, J.H. Haga, and W.R. Giles Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes Am. J. Physiol. Heart Circ. Physiol. 294 2008 H736 H749
145. P. Gergely, B. Nuesslein-Hildesheim, D. Guerini, V. Brinkmann, M. Traebert, C. Bruns, S. Pan, N.S. Gray, K. Hinterding, N.G. Cooke, A. Groenewegen, A. Vitaliti, T. Sing, O. Luttringer, J. Yang, A. Gardin, N. Wang, W.J. Crumb Jr., M. Saltzman, M. Rosenberg, E. Wallstrom, The selective S1P receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate: translation from preclinical to clinical studies, Br. J. Pharmacol. (in press), 10.1111/j.1476-5381.2012.02061.x.
146. L. Koyrakh, M.I. Roman, V. Brinkmann, and K. Wickman The heart rate decrease caused by acute FTY720 administration is mediated by the G protein-gated potassium channel I Am. J. Transplant. 5 2005 529 536
147. W.S. Szczepaniak, B.R. Pitt, and B.J. McVerry S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate Am. J. Physiol. Lung Cell. Mol. Physiol. 299 2010 L137 L145
148. A. Murakami, H. Takasugi, S. Ohnuma, Y. Koide, A. Sakurai, S. Takeda, T. Hasegawa, J. Sasamori, T. Konno, K. Hayashi, Y. Watanabe, K. Mori, Y. Sato, A. Takahashi, N. Mochizuki, and N. Takakura Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist Mol. Pharmacol. 77 2010 704 713
149. Y. Takuwa Subtype-specific differential regulation of Rho family G proteins and cell migration by the Edg family sphingosine-1-phosphate receptors Biochim. Biophys. Acta 1582 2002 112 120
150. I. Ishii, X. Ye, B. Friedman, S. Kawamura, J.J. Contos, M.A. Kingsbury, A.H. Yang, G. Zhang, J.H. Brown, and J. Chun Marked perinatal lethality and cellular signaling deficits in mice null for the two sphingosine 1-phosphate (S1P) receptors, S1P(2)/LP(B2)/EDG-5 and S1P(3)/LP(B3)/EDG-3 J. Biol. Chem. 277 2002 25152 25159
151. K. Yamashita, J. Kajstura, D.J. Discher, B.J. Wasserlauf, N.H. Bishopric, P. Anversa, and K.A. Webster Reperfusion-activated Akt kinase prevents apoptosis in transgenic mouse hearts overexpressing insulin-like growth factor-1 Circ. Res. 88 2001 609 614
152. D.J. Hausenloy, A. Tsang, M.M. Mocanu, and D.M. Yellon Ischemic preconditioning protects by activating prosurvival kinases at reperfusion Am. J. Physiol. Heart Circ. Physiol. 288 2005 H971 H976
153. M. Zhu, J. Feng, E. Lucchinetti, G. Fischer, L. Xu, T. Pedrazzini, M.C. Schaub, and M. Zaugg Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway Cardiovasc. Res. 72 2006 152 162
154. N. Ahmad, Y. Wang, K.H. Haider, B. Wang, Z. Pasha, O. Uzun, and M. Ashraf Cardiac protection by mitoKATP channels is dependent on Akt translocation from cytosol to mitochondria during late preconditioning Am. J. Physiol. Heart Circ. Physiol. 290 2006 H2402 H2408
155. H. Tong, W. Chen, C. Steenbergen, and E. Murphy Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C Circ. Res. 87 2000 309 315
156. M.M. Mocanu, R.M. Bell, and D.M. Yellon PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning J. Mol. Cell. Cardiol. 34 2002 661 668
157. E.E. Egom, T.M. Mohamed, M.A. Mamas, Y. Shi, W. Liu, D. Chirico, S.E. Stringer, Y. Ke, M. Shaheen, T. Wang, S. Chacko, X. Wang, R.J. Solaro, F. Fath-Ordoubadi, E.J. Cartwright, and M. Lei Activation of Pak1/Akt/eNOS signaling following sphingosine-1-phosphate release as part of a mechanism protecting cardiomyocytes against ischemic cell injury Am. J. Physiol. Heart Circ. Physiol. 301 2011 H1487 H1495
158. F. Vigneron, P. Dos Santos, S. Lemoine, M. Bonnet, L. Tariosse, T.
159. F. Tsuruta, N. Masuyama, and Y. Gotoh The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria J. Biol. Chem. 277 2002 14040 14047
160. S.J. Gardai, D.A. Hildeman, S.K. Frankel, B.B. Whitlock, S.C. Frasch, N. Borregaard, P. Marrack, D.L. Bratton, and P.M. Henson Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils J. Biol. Chem. 279 2004 21085 21095
161. S.R. Datta, H. Dudek, X. Tao, S. Masters, H. Fu, Y. Gotoh, and M.E. Greenberg Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery Cell 91 1997 231 241
162. T. Miura, and M. Tanno The mPTP and its regulatory proteins: final common targets of signalling pathways for protection against necrosis Cardiovasc. Res. 94 2012 181 189
163. S. Miyamoto, A.N. Murphy, and J.H. Brown Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II Cell Death Differ. 15 2008 521 529
164. J.E. Lee, G. Bokoch, and B.T. Liang A novel cardioprotective role of RhoA: new signaling mechanism for adenosine FASEB J. 15 2001 1886 1894
165. E.R. Sharlow, K.V. Giridhar, C.R. LaValle, J. Chen, S. Leimgruber, R. Barrett, K. Bravo-Altamirano, P. Wipf, J.S. Lazo, and Q.J. Wang Potent and selective disruption of protein kinase D functionality by a benzoxoloazepinolone J. Biol. Chem. 283 2008 33516 33526
166. M.V. Sofroniew, and H.V. Vinters Astrocytes: biology and pathology Acta Neuropathol. 119 2010 7 35
167. S.D. Sorensen, O. Nicole, R.D. Peavy, L.M. Montoya, C.J. Lee, T.J. Murphy, S.F. Traynelis, and J.R. Hepler Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes Mol. Pharmacol. 64 2003 1199 1209
168. D. Nayak, Y. Huo, W.X. Kwang, P.N. Pushparaj, S.D. Kumar, E.A. Ling, and S.T. Dheen Sphingosine kinase 1 regulates the expression of proinflammatory cytokines and nitric oxide in activated microglia Neuroscience 166 2010 132 144
169. V. Brinkmann, A. Billich, T. Baumruker, P. Heining, R. Schmouder, G. Francis, S. Aradhye, and P. Burtin Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis Nat. Rev. Drug Discov. 9 2010 883 897
170. V. Brinkmann, J.G. Cyster, and T. Hla FTY720: sphingosine 1-phosphate receptor-1 in the control of lymphocyte egress and endothelial barrier function Am. J. Transplant. 4 2004 1019 1025
171. M. Matloubian, C.G. Lo, G. Cinamon, M.J. Lesneski, Y. Xu, V. Brinkmann, M.L. Allende, R.L. Proia, and J.G. Cyster Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1 Nature 427 2004 355 360
172. S. Mandala, R. Hajdu, J. Bergstrom, E. Quackenbush, J. Xie, J. Milligan, R. Thornton, G.J. Shei, D. Card, C. Keohane, M. Rosenbach, J. Hale, C.L. Lynch, K. Rupprecht, W. Parsons, and H. Rosen Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists Science 296 2002 346 349
173. C.A. Foster, L.M. Howard, A. Schweitzer, E. Persohn, P.C. Hiestand, B. Balatoni, R. Reuschel, C. Beerli, M. Schwartz, and A. Billich Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: consequences for mode of action in multiple sclerosis J. Pharmacol. Exp. Ther. 323 2007 469 475
174. J.W. Choi, S.E. Gardell, D.R. Herr, R. Rivera, C.W. Lee, K. Noguchi, S.T. Teo, Y.C. Yung, M. Lu, G. Kennedy, and J. Chun FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation Proc. Natl. Acad. Sci. U. S. A. 108 2011 751 756
175. V.E. Miron, C.G. Jung, H.J. Kim, T.E. Kennedy, B. Soliven, and J.P. Antel FTY720 modulates human oligodendrocyte progenitor process extension and survival Ann. Neurol. 63 2008 61 71
176. M. Osinde, F. Mullershausen, and K.K. Dev Phosphorylated FTY720 stimulates ERK phosphorylation in astrocytes via S1P receptors Neuropharmacology 52 2007 1210 1218
177. C.G. Jung, H.J. Kim, V.E. Miron, S. Cook, T.E. Kennedy, C.A. Foster, J.P. Antel, and B. Soliven Functional consequences of S1P receptor modulation in rat oligodendroglial lineage cells Glia 55 2007 1656 1667
178. R. Perona, S. Montaner, L. Saniger, I. Sanchez-Perez, R. Bravo, and J.C. Lacal Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins Genes Dev. 11 1997 463 475
179. Y.S. Hwang, J.C. Hodge, N. Sivapurapu, and P.F. Lindholm Lysophosphatidic acid stimulates PC-3 prostate cancer cell Matrigel invasion through activation of RhoA and NF-kappaB activity Mol. Carcinog. 45 2006 518 529
180. Y. Harada, H. Edamatsu, and T. Kataoka PLCepsilon cooperates with the NF-kappaB pathway to augment TNFalpha-stimulated CCL2/MCP1 expression in human keratinocyte Biochem. Biophys. Res. Commun. 414 2011 106 111
181. T.T. Chiu, W.Y. Leung, M.P. Moyer, R.M. Strieter, and E. Rozengurt Protein kinase D2 mediates lysophosphatidic acid-induced interleukin 8 production in nontransformed human colonic epithelial cells through NF-kappaB Am. J. Physiol. Cell Physiol. 292 2007 C767 C777
182. E. Rozengurt Protein kinase D signaling: multiple biological functions in health and disease Physiology (Bethesda) 26 2011 23 33